What is JBIO's total equity?

JBIO (JBIO) reported total equity of $296.46M in Q1 2026.

How has JBIO's total equity changed year-over-year?

JBIO's total equity increased by 455.0% year-over-year, from -$83.51M to $296.46M.

What is the long-term trend for JBIO's total equity?

Over 5 years (2020 to 2025), JBIO's total equity has grown at a 90.2% compound annual growth rate (CAGR), from -$13.34M to $332.52M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

JBIO JBIO Total Equity

Total Equity at other companies

Vertex PharmaceuticalsVRTX

$19.36B+17.4%

Travere Therapeutics, Inc.TVTX

$98.73M+201%

Vera TherapeuticsVERA

$499.7M-6.6%

AnaptysBio, Inc.ANAB

$12.75M-62.5%

Cullinan Therapeutics, Inc.CGEM

$408.73M-30.8%

Viridian Therapeutics, Inc.VRDN

$636.01M+5.2%

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Market cap$1.33B—

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's total equity?: JBIO (JBIO) reported total equity of $296.46M in Q1 2026.
How has JBIO's total equity changed year-over-year?: JBIO's total equity increased by 455.0% year-over-year, from -$83.51M to $296.46M.
What is the long-term trend for JBIO's total equity?: Over 5 years (2020 to 2025), JBIO's total equity has grown at a 90.2% compound annual growth rate (CAGR), from -$13.34M to $332.52M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.